Loading clinical trials...

Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01287988

Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies

The primary objective of this study is to assess visual function in up to 44 patients who have previously participated in either of the placebo controlled, ocriplasmin Phase III studies (TG-MV-006 or ...

Lead sponsor: ThromboGenics•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Ocriplasmin Research to Better Inform Treatment (ORBIT)

NCT02079883 · Symptomatic Vitreomacular Adhesion

COMPLETED

A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA

NCT02193945 · Symptomatic Vitreomacular Adhesion (VMA)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 13, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment24

Start dateMay 2011

Last updatedJan 13, 2017

Condition

Symptomatic Vitreomacular Adhesion

Locations shown

Retinal Consultants of Houston

Houston, Texas

Universitaire Ziekenhuizen K.U. Leuven

Leuven

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions